Inventor · disambiguated record
Joseph Henri Bayle
Also filed as: BAYLE JOSEPH HENRI
2 granted patents·9 pending applications·0 citations·filing 2015–2025
28Inventor score
Top patents by PatentIndex Score
11 records- 0169US2024368574A1Dual controls for therapeutic cell activation or eliminationUNIV TEXAS·Filed 2023·Application pending·0 cites
- 0266US12410231B2Natural killer cell products and methodsUNIV TEXAS·Filed 2019·Granted Sep 9, 2025·0 cites·18 claims
- 0357US2022125837A1Methods for controlled elimination of therapeutic cellsBELLICUM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0456US12269861B2Chimeric ILT receptor compositions and methodsNKILT THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·19 claims
- 0556US2022152100A1Methods for controlled activation or elimination of therapeutic cellsBELLICUM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0655US2023065562A1Dual controls for therapeutic cell activation or eliminationBELLICUM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0744US2021147507A1Methods to augment or alter signal transductionBELLICUM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0844US2025257114A1Chimeric ilt receptor compositions and methodsNKILT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0941US2017166877A1Dual controls for therapeutic cell activation or eliminationBELLICUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1037US2016166613A1Methods for controlled elimination of therapeutic cellsBELLICUM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1135US2016175359A1Methods for controlled activation or elimination of therapeutic cellsBELLICUM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Henri Bayle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →